Microequities | Finance

Microequities

Phone: +61 2 9009 2900

Add/Update information

Reviews

Tags

• Businesses
• Financial service
• Finance

17.01.2022 Microequities Investor 001 Shares His Real Million Dollar Story. Garry Krimotat became the first Microequities investor in the Deep Value Fund more than 12 years ago. He invested $100,000 in the Deep Value Fund. Today that investment is worth more than $1,000,000. At a special ceremony commemorating his long tenure and success with Microequities we conversed with Garry as he shared some of his investment wisdom in a revealing and delightful interview. Click to read the interview

03.01.2022 We are pleased to note that at the end of November, clients that invested $100,000 in the Fund at inception would have seen their investment grow to $1,000,000 in a period of 12.8 years. After all fees, the Microequities Deep Value Fund has returned +903.9%, compared to the All Ordinaries Accumulation Index return of +307.8% or the Small Ordinaries Accumulation Index return of +247.3% over the same period. The +903.9% over 12.8 years equates to +19.8% annual net compound returns (after all fees).

21.12.2021 Empired Ltd (ASX:EPD) today received a takeover offer at +65% premium to the last traded price. Microequities Asset Management is the largest shareholder of Empired with approximately 17% of the company across our various funds including our flagship Deep Value Fund and Pure Microcap Value Fund. For more information about our funds, please visit: https://microequities.com.au/our-funds/

18.12.2021 We invite you to join our insightful webinar for the soon to be launched Private to Beyond the IPO Fund. This webinar will be held on Friday, 9th July at 1:00pm (AEDT). Presenters:... Carlos Gil (Microequities Chief Investment Officer) Andrew Ross (Microequities Private Equity Portfolio Manager) Matthew Michalewicz (Artificial Intelligence expert and Complexica's CEO) Please register

11.12.2021 Our Chief Investment Officer Carlos Gil recently presented at the Coffee Microcaps Microcap Manager Monthly. We discussed two of our current portfolio holdings iSelect (ASX: ISU) & Complexica (Unlisted).

22.11.2021 Our Chief Investment Officer Carlos Gil discussed our ‘Private to Beyond the IPO Fund’ with The Australian Financial Review. He shared the strategy for our new fund.

11.11.2021 We are excited to announce that we have secured an investment in an Artificial Intelligence company Complexica for our new fund, "Private to Beyond the IPO Fund". We believe Complexica will become one of the reference Australian ASX-listed technology companies over the next decade and we are delighted to be a partner on that journey.

03.11.2021 We are pleased to announce that we are launching the "Private to Beyond the IPO Fund". The Fund will target select private equity investment opportunities, pre-IPO deals and a select few ASX-listed companies. We are in the advanced stages of securing a cornerstone proprietary private equity opportunity that is likely to be acquired before the Fund is launched. For more information, please visit:... https://microequities.com.au//private-to-beyond-the-ipo-f/ See more

22.10.2021 The microcap opportunity CEO of Microequities Asset Management Carlos Gil explains the appeal of investing in microcaps and the opportunities currently on offer in the space.

19.10.2021 Small cap stocks that should be on your radar. MicroEquities Asset Management’s Carlos Gil says Lark has international growth prospects. Lark has a whisky-making tradition and is known as a premium brand. It’s an example of a microcap Australian company that can export a unique product.

17.10.2021 Shareholders split on $503m Citadel acquisition bid

12.10.2021 Microequities Asset Management CEO, Carlos Gil, is buying microcap stocks that can survive and thrive during COVID-19. They need strong balance sheets and can weather the economic fallout. Then we want to know the company can thrive after the crisis as more people use its products or services, he says. Gil says emerging software-as-a-service companies fit this criteria and favours medical technology firms such as Integral Diagnostics. He expects a wave of micro-cap takeover activity in the next 18 months as cashed-up private-equity firms pounce. A lot of quality micro-cap companies are 30-40 per cent cheaper than they were before COVID-19 and have good prospects.

03.10.2021 Strong 1H20 reporting season but the market is Covid-19 focused

16.09.2021 Meet the Manager Q/A with Microequities CIO Carlos Gil via Asendium You will learn about - Who is Microequities?... What is Microequities investment philosophy? Why should investors invest with Microequities? Why does Microequities invest in microcap and small cap businesses? What is Microequities view of the current market? See more